HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Falk Leichsenring Selected Research

Neurotic Disorders (Neuroses)

1/2007[Results of psychoanalytic long-term therapy in specific diagnostic groups: improvement in symptoms and interpersonal relationships].
1/2004Quality of depressive experiences in borderline personality disorders: differences between patients with borderline personality disorder and patients with higher levels of personality organization.
10/2002Emotions as wishes and beliefs.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Falk Leichsenring Research Topics

Disease

15Social Phobia
01/2022 - 01/2007
11Mental Disorders (Mental Disorder)
02/2022 - 01/2006
8Anxiety Disorders (Anxiety Disorder)
01/2019 - 01/2002
6Personality Disorders (Personality Disorder)
01/2019 - 01/2002
4Depressive Disorder (Melancholia)
01/2020 - 12/2014
3Neurotic Disorders (Neuroses)
01/2007 - 10/2002
2Somatoform Disorders (Somatoform Disorder)
01/2019 - 01/2015
2Major Depressive Disorder (Major Depressive Disorders)
01/2017 - 01/2015
2Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive)
01/2017 - 10/2016
1Wounds and Injuries (Trauma)
12/2020
1Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder)
12/2020
1Inflammation (Inflammations)
01/2020
1Panic Disorder (Panic Attack)
01/2015
1Dysthymic Disorder
01/2015
1Anorexia Nervosa
01/2015
1Substance-Related Disorders (Drug Abuse)
01/2015
1Mood Disorders (Mood Disorder)
01/2007
1Borderline Personality Disorder (Personality Disorders, Borderline)
01/2007
1Self Mutilation
01/2006

Drug/Important Bio-Agent (IBA)

121-phenyl-3,3-dimethyltriazene (PDT)IBA
12/2020 - 01/2013
2N 30IBA
01/2004 - 10/2002
1HMGB1 Protein (HMG1)IBA
01/2020
14-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA
01/2020
1C-Reactive ProteinIBA
01/2020
1LeptinIBA
01/2020
1E 10 (E-10)IBA
05/2017
1Dopamine (Intropin)FDA LinkGeneric
01/2011
1Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA
01/2011

Therapy/Procedure

37Therapeutics
01/2022 - 01/2002
3Drug Therapy (Chemotherapy)
02/2022 - 10/2017
1Aftercare (After-Treatment)
10/2008